In terms of population characteristics, age, gender, histology, clinical stage, first-line immunotherapy and therapeutic Regimen did not show a significant trend toward primary drug resistance (Table 2 , Table S1, S2, S3).
← all excerpts
Inflammatory markers predict efficacy of immunotherapy in advanced non-small cell lung cancer: a preliminary exploratory study.
1
—
—